News on Fms-Like_Tyrosine_Kinase_3 from BioPortfolio.com http://www.BioPortfolio.com Consolidated Fms-Like_Tyrosine_Kinase_3 news from BioPortfolio.com Wed, 10 Feb 2010 11:52:56 GMT en Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Bhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033635&HITNO=0&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033635&THISHREF=http://c.moreover.com/click/here.pl%3fz2535298573%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033635&HITNO=0&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033635&THISHREF=http://c.moreover.com/click/here.pl%3fz2535298573%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJournal of Clinical Oncology: Research and Markets: Targeting Protein Kinases for Cancer Therap...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3982882&HITNO=1&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3982882&THISHREF=http://c.moreover.com/click/here.pl%3fz2507605852%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3982882&HITNO=1&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3982882&THISHREF=http://c.moreover.com/click/here.pl%3fz2507605852%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Research and Markets: Targeting Protein Kinases for Cancer Therapy: An Expert Guide to Targeting Protein Kinases in Cancer Therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3982525&HITNO=2&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3982525&THISHREF=http://c.moreover.com/click/here.pl%3fz2507486563%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3982525&HITNO=2&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3982525&THISHREF=http://c.moreover.com/click/here.pl%3fz2507486563%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Research and Markets: Targeting Protein Kinases for Cancer Therapy: An Expert Guide to Targeting Protein Kinases in Cancer Therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3982469&HITNO=3&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3982469&THISHREF=http://c.moreover.com/click/here.pl%3fz2507470407%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3982469&HITNO=3&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3982469&THISHREF=http://c.moreover.com/click/here.pl%3fz2507470407%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Research and Markets: Targeting Protein Kinases for Cancer Therapy: An Expert Guide to Targeting Proteinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3982425&HITNO=4&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3982425&THISHREF=http://c.moreover.com/click/here.pl%3fz2507451028%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3982425&HITNO=4&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3982425&THISHREF=http://c.moreover.com/click/here.pl%3fz2507451028%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Research and Markets: Targeting Protein Kinases for Cancer Therapy: An Expert Guide to Targeting Protein Kinashttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3982337&HITNO=5&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3982337&THISHREF=http://c.moreover.com/click/here.pl%3fz2507405009%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3982337&HITNO=5&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3982337&THISHREF=http://c.moreover.com/click/here.pl%3fz2507405009%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Research and Markets: Targeting Protein Kinases for Cancer Therapy: An Expert Guide to Targeting Protein Kinases in Canchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3982328&HITNO=6&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3982328&THISHREF=http://c.moreover.com/click/here.pl%3fz2507400078%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3982328&HITNO=6&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3982328&THISHREF=http://c.moreover.com/click/here.pl%3fz2507400078%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Clinical Pharmacokinetics of the BCRABL Tyrosine Kinase Inhibitor Nilotinibhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974576&HITNO=7&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974576&THISHREF=http://c.moreover.com/click/here.pl%3fz2503593922%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974576&HITNO=7&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974576&THISHREF=http://c.moreover.com/click/here.pl%3fz2503593922%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comClinical Pharmacology & Therapeutics: RON Receptor Tyrosine Kinase as a Target for Delivery of Chemodrugs by Antibody Directed Pathway for Cancer Cell Cytotoxicityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978636&HITNO=8&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978636&THISHREF=http://c.moreover.com/click/here.pl%3fz2505379968%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3978636&HITNO=8&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3978636&THISHREF=http://c.moreover.com/click/here.pl%3fz2505379968%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMolecular Pharmaceutics: Enzyme Research: New enzyme research study findings recently were published by researchers at INSERMhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3953972&HITNO=9&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3953972&THISHREF=http://c.moreover.com/click/here.pl%3fz2492279143%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3953972&HITNO=9&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3953972&THISHREF=http://c.moreover.com/click/here.pl%3fz2492279143%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Data Presented at the AACR -- IASLC Conference on the Molecular Origins of Lung Cancer Demonstrate Lower Rates of T790M-Mediated Resistance With XL647 Than With Other EGFR Tyrosine Kinase Inhibitorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3905001&HITNO=10&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3905001&THISHREF=http://c.moreover.com/click/here.pl%3fz2465966717%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3905001&HITNO=10&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3905001&THISHREF=http://c.moreover.com/click/here.pl%3fz2465966717%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDMN Newswire: Data Presented at the AACR -- IASLC Conference on the Molecular Origins of Lung Cancer Demonstrate Lower Rates of T790M-Mediated Resistance With XL647 Than With Other EGFR Tyrosine Kinase Inhibitorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904754&HITNO=11&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904754&THISHREF=http://c.moreover.com/click/here.pl%3fz2465853858%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904754&HITNO=11&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904754&THISHREF=http://c.moreover.com/click/here.pl%3fz2465853858%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Data Presented at the AACR -- IASLC Conference on the Molecular Origins of Lung Cancer Demonstrate Lower Rates of T790M-Mediated Resistance With XL647 Than With Other EGFR Tyrosine Kinase Inhibitorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904662&HITNO=12&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904662&THISHREF=http://c.moreover.com/click/here.pl%3fz2465785678%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904662&HITNO=12&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904662&THISHREF=http://c.moreover.com/click/here.pl%3fz2465785678%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: INTERESTing Biomarker to Select IDEAL Patients for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3897945&HITNO=13&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3897945&THISHREF=http://c.moreover.com/click/here.pl%3fz2462533631%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3897945&HITNO=13&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3897945&THISHREF=http://c.moreover.com/click/here.pl%3fz2462533631%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJournal of Clinical Oncology: EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet-Fed Mhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3873996&HITNO=14&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3873996&THISHREF=http://c.moreover.com/click/here.pl%3fz2450250526%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3873996&HITNO=14&MSIZE=18&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Fms-Like_Tyrosine_Kinase_3&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3873996&THISHREF=http://c.moreover.com/click/here.pl%3fz2450250526%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDiabetes: